$9.75
-0.27-2.69%
가까이에: Nov 16, 4:00 PM EST
$9.75
N/A
시간외: 4:00 PM EST

The average analyst price target for Bicara Therapeutics is $29.50, 202.6% above the current price. Of 14 analysts, 12 rate it Buy, 1 Hold and 1 Sell. Targets range from $8 to $43. The latest change came on Nov 11, 2026, when HC Wainwright & Co. lowered its price target on Bicara Therapeutics from $42 to $36 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 14 Analysts
Rating Trend — Last 9 Months